A vaccine against Zika virus is safe and effective when administered both before and during pregnancy, according to new research published in npj Vaccines.
Mar 4, 2024
0
12
Researchers at the National Institutes of Health have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored "dark side" of the neuraminidase (NA) protein ...
Mar 1, 2024
0
50
The eyes have been called the window to the brain. It turns out they also serve as an immunological barrier that protects the organ from pathogens and even tumors, Yale researchers have found.
Feb 28, 2024
0
19
A University of Alberta research team has uncovered a new class of drugs with the potential to prevent or treat infections in a future viral outbreak.
Feb 22, 2024
0
12
Society learned about the value of mRNA during the COVID-19 pandemic when we saw scientists and medical professionals harness its power to deliver a vaccine for the virus within a year.
Feb 20, 2024
0
15
A multidisciplinary team at the University of Alberta is seeking to understand how monkeypox (mpox) virus may be causing neurological symptoms in people affected by the global outbreak of mpox disease, declared by the World ...
Feb 16, 2024
0
10
People infected with the chikungunya virus (CHIKV) still have an increased risk of death from complications for up to three months post-infection, according to new research published in The Lancet Infectious Diseases.
Feb 13, 2024
0
21
Just over a year ago, the European Union and the US Food and Drug Administration approved a new anti-retroviral drug to treat human immunodeficiency virus (HIV) infections. Lenacapavir is the first drug available to patients ...
Feb 13, 2024
0
8
Findings from a new study conducted by a team of researchers at Dartmouth's Geisel School of Medicine and Thayer School of Engineering and published in Cell Reports Medicine offer new insights into how antibodies function ...
Feb 12, 2024
0
66
A multi-institutional team of Chinese microbiologists and pharmacologists has developed a novel way to fight cancerous tumors. Called ONCOTECH, it combines oncolytic virotherapy and adoptive T cell therapy for treatment of ...
